Security Reporting

At ScreenPoint Medical, the security of our systems and the safety of patient data are paramount. We are committed to maintaining the highest standards of cybersecurity across all our products and services, including our AI-driven breast cancer detection software, Transpara®.

We recognize the vital role that security researchers, customers, and partners play in helping us uphold this commitment. If you discover a potential security vulnerability in any of our systems, we encourage you to report it to us promptly and responsibly.

 

Reporting a Vulnerability

If you believe you have discovered a security vulnerability, please contact our Security Team via the following dedicated email address:

security [at] screenpointmed [dot] com

To help us triage and respond to your report effectively, please include the following details:

• A description of the vulnerability and the affected system or product (e.g., Transpara version, component)

• Steps to reproduce the issue

• Any relevant logs, screenshots, or proof-of-concept code (if applicable)

• Your contact information (so we can follow up if needed)

We ask that you:

• Avoid publicly disclosing the vulnerability until we have had a reasonable opportunity to investigate and remediate it

• Do not access, modify, or delete data that does not belong to you

• Comply with all applicable laws during your research

  
  
  

Responsible Disclosure Program

While we currently do not operate a formal bug bounty program, we deeply value contributions from the security community. If your report leads to a confirmed vulnerability, we would be happy to recognize your efforts.

ScreenPoint Medical is committed to secure, ethical, and compliant product development. Our security program is aligned with ISO/IEC 27001 standards.